# Ophthalmic Agents: Glaucoma Agents

## Authorizations

365 Days

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval?

Acceptable reasons include:

- Allergy to medications not requiring prior approval

- Contraindications to or drug interaction with medications not requiring prior approval

- History of unacceptable/toxic side effects to medications not requiring prior approval

## Step Therapy

1. For a product requiring step therapy, there must have been inadequate clinical response to preferred alternatives for glaucoma, including a trial of no less than **30 days** of at least **one** preferred product
2. For a non-preferred agent for glaucoma, there must have been inadequate clinical response to preferred alternatives, including a trial of no less than **30 days each** of at least **two** preferred or step therapy products

## Glaucoma Agents

Ophthalmic Agents: Glaucoma Agents

| PREFERRED | NON-PREFERRED |
| :--- | ---: |
| Alphagan P 0.1% ST  | Apraclonidine     |
| Alphagan P 0.15% Bv | Betoptic S        |
| Azopt BvG ST        | Bimatoprost       |
| Betaxolol           | Brimonidine 0.15% |
| Brimonidine 0.2%    | Brinzolamide      |
| Carteolol           | Iopidine          |
| Combigan BvG ST     | Istalol           |
| Dorzolamide         | Lumigan           |
| Dorzolamide/Timolol | Travoprost        |
| Latanaprost         | Vyzulta           |
| Levobunolol         | Xelpros           |
| Metipranolol        | Zioptan           |
| Rhopressa           |                   |
| Rocklatan           |                   |
| Simbrinza           |                   |
| Timolol             |                   |
| Travatan Z BvG ST   |                   |

### Link to Criteria

[Ophthalmic Agents: Glaucoma Agents](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=84)
